Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage.
Brown
K T
KT
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Kemeny
N
N
Berger
M F
MF
Getrajdman
G I
GI
Napp
T
T
Fong
Y
Y
Herman
S
S
Kurtz
R C
RC
Botet
J
J
Blumgart
L H
LH
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D002758:Cholangiography; D002779:Cholestasis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000628:therapy; D004322:Drainage / Q000009:adverse effects / Q000379:methods; D005260:Female; D006470:Hemorrhage / Q000209:etiology; D006499:Hepatic Artery; D006801:Humans; D007260:Infusion Pumps; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000009:adverse effects; D015996:Survival Rate
D016685:Mitomycin